- Author: Eyal Muscal, MD, MS; Chief Editor: Lawrence K Jung, MD more...
Because patients may present without any obvious history or physical sign of rhabdomyolysis, clinicians must be aware of the potentially subtle presentation and keep the possibility of rhabdomyolysis in mind. In the evaluation of blunt trauma in children, it is vital to remain vigilant for signs of child abuse (nonaccidental injury). Consider rhabdomyolysis in cases of child abuse, drug-overdoses, heat-related events and pediatric orthopedic injuries.
Failure to consider this diagnosis could result in the most severe complication of rhabdomyolysis: pigment-associated renal inury. Rhabdomyolysis accounts for 5-25% of cases of acute kidney injury (AKI) in adult patients; rates in pediatric patients are unknown.
Useful laboratory tests that should be ordered include the following:
Complete blood count (CBC), including hemoglobin, hematocrit, and platelets
Serum chemistries, including blood urea nitrogen (BUN), creatinine, glucose, calcium, potassium, phosphate, uric acid, and liver function tests (LFTs)
Prothrombin time (PT)
Activated partial thromboplastin time (aPTT) – Thromboplastin released from injured myocytes can cause disseminated intravascular coagulation (DIC)
Lactate dehydrogenase (LDH)
Hyperkalemia, an immediate threat to life in the hours immediately after injury, occurs in 10-40% of cases. Liberated potassium can cause life-threatening dysrhythmias and death. Hyperphosphatemia does not require specific therapy. Hypocalcemia occurs early in the course of rhabdomyolysis. Supplemental calcium is not recommended. Increased purine metabolism causes hyperuricemia. Specific therapy with uricosuric agents or allopurinol is not indicated.
The BUN-creatinine ratio may be decreased because of the conversion of liberated muscle creatine to creatinine. In an emergency department (ED)-based study of 97 adults with rhabdomyolysis, no patient presenting in an ED setting with an initial creatinine level of less than 1.7 mg/dL developed ARF.
One series of 109 ED patients with rhabdomyolysis found that 50% had an elevated cardiac troponin I level. Of these, 58% were ultimately found (on the basis of electrocardiography [ECG] and echocardiography) to be true positives, 33% were false positives, and 9% were indeterminate.
A study analyzed the specific features and mortality of patients with rhabdomyolysis and the relation between creatinine, creatinkinase and mortality. The study concluded that despite being a diagnostic marker for rhabdomyolysis, initials creatinkinase levels do not predict mortality. However, the authors added that creatinine initial levels are related to progression to acute renal injury and mortality at 30 days.
The diagnosis of rhabdomyolysis can be confirmed using certain laboratory studies. The most reliable and sensitive indicator of muscle injury is creatine kinase (CK). Assessing CK levels is most useful because of its ease of detection in serum and its presence in serum immediately after muscle injury.
CK levels rise within 12 hours of muscle injury, peak in 24-36 hours, and decrease at a rate of 30-40% per day. The serum half-life of CK is approximately 36 hours. CK levels decline 3-5 days after resolution of muscle injury ; failure of CK levels to decrease suggests ongoing muscle injury or development of a compartment syndrome. The peak CK level, especially when it is higher than 15,000 U/L, may be predictive of renal failure.
Total CK elevation is a sensitive but nonspecific marker for rhabdomyolysis. CK levels 5 times the reference range suggest rhabdomyolysis, though CK levels in rhabdomyolysis are frequently as high as 100 times the reference range or even higher. Suspect early rhabdomyolysis in patients with serum CK levels in excess of 2-3 times the reference range and risk factors for rhabdomyolysis; initiate a full laboratory workup. Because the total CK may increase from the initial values, draw repeat total CK levels every 6-12 hours until a peak level is established.
Plasma myoglobin measurements are not reliable, because myoglobin has a half-life of 1-3 hours and is cleared from plasma within 6 hours. Myoglobin levels not measured at the right time may produce a false-negative result, though a positive result may help confirm the diagnosis. Urine myoglobin measurements are therefore preferable.
A urine myoglobin assay is helpful in patients with coexisting hematuria (confirmed with microscopic examination) when the presence of myoglobin is suspected. A urine dipstick test for blood that has positive findings in the absence of red blood cells (RBCS) suggests myoglobinuria. Myoglobinuria may be sporadic or resolve early in the course of rhabdomyolysis. Urine dipstick findings are positive in fewer than 50% of patients with rhabdomyolysis; thus, a normal test result does not rule out this condition.
Radiography, CT, and MRI
Imaging studies generally play little role in the initial diagnosis of rhabdomyolysis. However, radiographs should be obtained when fractures are suspected. Computed tomography (CT) of the head may be necessary on a case-by-case basis when a patient with an altered sensorium is evaluated. Patients with significant head trauma may require head CT. A head CT scan may also be obtained in patients with first-time seizure activity or prolonged seizures or in patients with neurologic deficits of unknown etiology.
Magnetic resonance imaging (MRI) may be useful in distinguishing various etiologies of myopathy. One study suggests that bacterial myositis, focal myositis, and idiopathic rhabdomyolysis show a characteristic gadolinium enhancement on MRI. Abscesses were found only in bacterial myositis. Polymyositis and dermatomyositis have a characteristic uniform distribution pattern with emphasis on the quadriceps muscles.
MRI is the imaging modality of choice for evaluating the distribution and extent of injury of affected muscles, especially when fasciotomy or involvement of deep compartments is considered.
ECG should be performed early in the course of evaluation to evaluate for cardiac dysrhythmias related to hyperkalemia or hypocalcemia. ECG may reveal changes reflective of acute hyperkalemia, including peaked T waves, prolongation of the PR and QRS intervals, and loss of the P wave or the sine wave. Specific disease testing may be indicated to determine definitive causes during or after short-term management of rhabdomyolysis.
The compartment pressures should be measured in any patient with severe focal muscle tenderness and a firm muscle compartment. A fasciotomy may be needed if compartment pressures in excess of 25-30 mm Hg are sustained.
Histology demonstrates necrotic muscle fibers in patients with rhabdomyolysis. A muscle biopsy may be required to demonstrate immunohistochemical features of necrosis only if underlying and often inherited muscle disease is a concern. Immunoblotting, immunofluorescence, and genetic studies may be necessary to find evidence of inflammatory conditions or dystrophinopathies.
Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000 Aug. 11(8):1553-61. [Medline]. [Full Text].
Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988 Sep. 255(3 Pt 2):F539-44. [Medline].
Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009 Jul 2. 361(1):62-72. [Medline].
Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem. 2000 Sep. 37 ( Pt 5):581-7. [Medline].
Better OS. The crush syndrome revisited (1940-1990). Nephron. 1990. 55(2):97-103. [Medline].
Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006 Nov. 118(5):2119-25. [Medline].
Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010 Jun. 48(6):749-56. [Medline].
Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore). 1982 May. 61(3):141-52. [Medline].
Watemberg N, Leshner RL, Armstrong BA, Lerman-Sagie T. Acute pediatric rhabdomyolysis. J Child Neurol. 2000 Apr. 15(4):222-7. [Medline].
Elsayed EF, Reilly RF. Rhabdomyolysis: a review, with emphasis on the pediatric population. Pediatr Nephrol. 2010 Jan. 25(1):7-18. [Medline].
Luck RP, Verbin S. Rhabdomyolysis: a review of clinical presentation, etiology, diagnosis, and management. Pediatr Emerg Care. 2008 Apr. 24(4):262-8. [Medline].
Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am. 1992 Aug. 39(4):821-58. [Medline].
Sitprija V. Animal toxins and the kidney. Nat Clin Pract Nephrol. 2008 Nov. 4(11):616-27. [Medline].
Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care. 2005 Apr. 9(2):158-69. [Medline]. [Full Text].
Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin. 2004 Jan. 20(1):171-92. [Medline].
Schwengel D, Ludwig S. Rhabdomyolysis and myoglobinuria as manifestations of child abuse. Pediatr Emerg Care. 1985 Dec. 1(4):194-7. [Medline].
Peebles J, Losek JD. Child physical abuse and rhabdomyolysis: case report and literature review. Pediatr Emerg Care. 2007 Jul. 23(7):474-7. [Medline].
Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis. 1996 Apr. 22(4):642-9. [Medline].
Nauss MD, Schmidt EL, Pancioli AM. Viral myositis leading to rhabdomyolysis: a case report and literature review. Am J Emerg Med. 2009 Mar. 27(3):372.e5-372.e6. [Medline].
Patel N, Patel N, Espinoza LR. HIV infection and rheumatic diseases: the changing spectrum of clinical enigma. Rheum Dis Clin North Am. 2009 Feb. 35(1):139-61. [Medline].
Wang YM, Zhang Y, Ye ZB. Rhabdomyolysis following recent severe coxsackie virus infection in patient with chronic renal failure: one case report and a review of the literature. Ren Fail. 2006. 28(1):89-93. [Medline].
Pirounaki M, Liatsos G, Elefsiniotis I, Skounakis M, Moulakakis A. Unusual onset of varicella zoster reactivation with meningoencephalitis, followed by rhabdomyolysis and renal failure in a young, immunocompetent patient. Scand J Infect Dis. 2007. 39(1):90-3. [Medline].
Gupta M, Ghaffari M, Freire AX. Rhabdomyolysis in a patient with West Nile encephalitis and flaccid paralysis. Tenn Med. 2008 Apr. 101(4):45-7. [Medline].
Eliasson H, Broman T, Forsman M, Bäck E. Tularemia: current epidemiology and disease management. Infect Dis Clin North Am. 2006 Jun. 20(2):289-311, ix. [Medline].
Antonarakis ES, Wung PK, Durand DJ, Leyngold I, Meyerson DA. An atypical complication of atypical pneumonia. Am J Med. 2006 Oct. 119(10):824-7. [Medline].
Weng WC, Peng SS, Wang SB, Chou YT, Lee WT. Mycoplasma pneumoniae--associated transverse myelitis and rhabdomyolysis. Pediatr Neurol. 2009 Feb. 40(2):128-30. [Medline].
Turhan V, Atasoyu EM, Kucukardali Y, Polat E, Cesur T, Cavuslu S. Leptospirosis presenting as severe rhabdomyolysis and pulmonary haemorrhage. J Infect. 2006 Jan. 52(1):e1-2. [Medline].
Lin AC, Lin CM, Wang TL, Leu JG. Rhabdomyolysis in 119 students after repetitive exercise. Br J Sports Med. 2005 Jan. 39(1):e3. [Medline]. [Full Text].
Scheuerman O, Wanders RJ, Waterham HR, Dubnov-Raz G, Garty BZ. Mitochondrial trifunctional protein deficiency with recurrent rhabdomyolysis. Pediatr Neurol. 2009 Jun. 40(6):465-7. [Medline].
Korematsu S, Kosugi Y, Kumamoto T, Yamaguchi S, Izumi T. Novel mutation of early, perinatal-onset, myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency. Pediatr Neurol. 2009 Aug. 41(2):151-3. [Medline].
Löfberg M, Jänkälä H, Paetau A, Härkönen M, Somer H. Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand. 1998 Oct. 98(4):268-75. [Medline].
Agrawal S, Agrawal V, Taneja A. Hypokalemia causing rhabdomyolysis resulting in life-threatening hyperkalemia. Pediatr Nephrol. 2006 Feb. 21(2):289-91. [Medline].
Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med. 1992 May. 92(5):455-7. [Medline].
Strachan P, Prisco D, Multz AS. Recurrent rhabdomyolysis associated with polydipsia-induced hyponatremia - a case report and review of the literature. Gen Hosp Psychiatry. 2007 Mar-Apr. 29(2):172-4. [Medline].
Lichtstein DM, Arteaga RB. Rhabdomyolysis associated with hyperthyroidism. Am J Med Sci. 2006 Aug. 332(2):103-5. [Medline].
Pedrozzi NE, Ramelli GP, Tomasetti R, Nobile-Buetti L, Bianchetti MG. Rhabdomyolysis and anesthesia: a report of two cases and review of the literature. Pediatr Neurol. 1996 Oct. 15(3):254-7. [Medline].
Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003 Jun. 111(6 Pt 1):1447-52. [Medline]. [Full Text].
Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr. 2004 Apr. 16(2):206-10. [Medline].
Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006 Jun. 96(6):678-85. [Medline].
Ahn SC. Neuromuscular complications of statins. Phys Med Rehabil Clin N Am. 2008 Feb. 19(1):47-59, vi. [Medline].
Oshima Y. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med. 2011. 50(8):845-53. [Medline].
Wrenn KD, Oschner I. Rhabdomyolysis induced by a caffeine overdose. Ann Emerg Med. 1989 Jan. 18(1):94-7. [Medline].
Holoshitz N, Alsheikh-Ali AA, Karas RH. Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use. Am J Cardiol. 2008 Jan 1. 101(1):95-7. [Medline].
Hung CF, Huang TY, Lin PY. Hypothermia and rhabdomyolysis following olanzapine injection in an adolescent with schizophreniform disorder. Gen Hosp Psychiatry. 2009 Jul-Aug. 31(4):376-8. [Medline].
Wysowski DK, Pollock ML. Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review. Anesthesiology. 2006 Nov. 105(5):1047-51. [Medline].
Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004 Dec 1. 292(21):2585-90. [Medline].
Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003 Apr 2. 289(13):1681-90. [Medline].
Urso ML, Clarkson PM, Hittel D, Hoffman EP, Thompson PD. Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. Arterioscler Thromb Vasc Biol. 2005 Dec. 25(12):2560-6. [Medline]. [Full Text].
Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med. 2009 Jun 16. 150(12):858-68. [Medline].
Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004 Jul 21. 292(3):331-7. [Medline].
Kao LW, Nañagas KA. Toxicity associated with carbon monoxide. Clin Lab Med. 2006 Mar. 26(1):99-125. [Medline].
Aslam AF, Aslam AK, Vasavada BC, Khan IA. Hypothermia: evaluation, electrocardiographic manifestations, and management. Am J Med. 2006 Apr. 119(4):297-301. [Medline].
Bergeron MF, McKeag DB, Casa DJ, Clarkson PM, Dick RW, Eichner ER, et al. Youth football: heat stress and injury risk. Med Sci Sports Exerc. 2005 Aug. 37(8):1421-30. [Medline].
Hurley JK. Severe rhabdomyolysis in well conditioned athletes. Mil Med. 1989 May. 154(5):244-5. [Medline].
Sinert R, Kohl L, Rainone T, Scalea T. Exercise-induced rhabdomyolysis. Ann Emerg Med. 1994 Jun. 23(6):1301-6. [Medline].
Chen YJ, Chang SH, Yuan A, Huang CH, Lee CC. Rhabdomyolysis after successful resuscitation of a patient with near-fatal asthma. Am J Emerg Med. 2007 Jul. 25(6):736.e3-4. [Medline].
Mehta R, Fisher LE Jr, Segeleon JE, Pearson-Shaver AL, Wheeler DS. Acute rhabdomyolysis complicating status asthmaticus in children: case series and review. Pediatr Emerg Care. 2006 Aug. 22(8):587-91. [Medline].
Song SH, Lee DW, Lee SB, Kwak IS. Rhabdomyolysis caused by strenuous computer gaming. Nephrol Dial Transplant. 2007 Apr. 22(4):1263-4. [Medline].
Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005 Nov. 84(6):377-85. [Medline].
Wu CT, Huang JL, Lin JJ, Hsia SH. Factors associated with nontraumatic rhabdomyolysis and acute renal failure of children in Taiwan population. Pediatr Emerg Care. 2009 Oct. 25(10):657-60. [Medline].
Chamberlain MC. Rhabdomyolysis in children: a 3-year retrospective study. Pediatr Neurol. 1991 May-Jun. 7(3):226-8. [Medline].
Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1988 Jul. 148(7):1553-7. [Medline].
Fernandez WG, Hung O, Bruno GR, Galea S, Chiang WK. Factors predictive of acute renal failure and need for hemodialysis among ED patients with rhabdomyolysis. Am J Emerg Med. 2005 Jan. 23(1):1-7. [Medline].
Li SF, Zapata J, Tillem E. The prevalence of false-positive cardiac troponin I in ED patients with rhabdomyolysis. Am J Emerg Med. 2005 Nov. 23(7):860-3. [Medline].
Baeza-Trinidad R, Brea-Hernando A, Morera-Rodriguez S, Brito-Diaz Y, Sanchez-Hernandez S, El Bikri L, et al. Creatinine as predictor value of mortality and acute kidney injury in rhabdomyolysis. Intern Med J. 2015 May 26. [Medline].
Lappalainen H, Tiula E, Uotila L, Mänttäri M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med. 2002 Oct. 30(10):2212-5. [Medline].
Minnema BJ, Neligan PC, Quraishi NA, Fehlings MG, Prakash S. A case of occult compartment syndrome and nonresolving rhabdomyolysis. J Gen Intern Med. 2008 Jun. 23(6):871-4. [Medline]. [Full Text].
Young SE, Miller MA, Docherty M. Urine dipstick testing to rule out rhabdomyolysis in patients with suspected heat injury. Am J Emerg Med. 2009 Sep. 27(7):875-7. [Medline].
Salluzzo R, Schwartz M,. Rhabdomyolysis. Emergency Clinical Practice. 4th ed. 1998. 2478-86.
Moratalla MB, Braun P, Fornas GM. Importance of MRI in the diagnosis and treatment of rhabdomyolysis. Eur J Radiol. 2008 Feb. 65(2):311-5. [Medline].
[Guideline] Finnish Medical Society Duodecim. Rhabdomyolysis. EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Apr 12. [Full Text].
Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med. 1990 Mar 22. 322(12):825-9. [Medline].
Iraj N, Saeed S, Mostafa H, Houshang S, Ali S, Farin RF, et al. Prophylactic fluid therapy in crushed victims of Bam earthquake. Am J Emerg Med. 2011 Sep. 29(7):738-42. [Medline].
Gunn VL, Nechyba C, eds. The Harriet Lane Handbook. 16th ed. St Louis, MO: Mosby Elsevier, Inc.; 2002. 45:
Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. J Trauma. 2004 Jun. 56(6):1191-6. [Medline].
Sever MS, Vanholder R, Lameire N. Management of crush-related injuries after disasters. N Engl J Med. 2006 Mar 9. 354(10):1052-63. [Medline].
Thoenes M. Rhabdomyolysis: when exercising becomes a risk. J Pediatr Health Care. 2010 May-Jun. 24(3):189-93. [Medline].
Harding A. New risk score predicts outcome in rhabdomyolysis. Medscape Medical News. September 4, 2013. Available at http://www.medscape.com/viewarticle/810443. Accessed: September 9, 2013.
McMahon GM, Zeng X, Waikar SS. A Risk Prediction Score for Kidney Failure or Mortality in Rhabdomyolysis. JAMA Intern Med. 2013 Sep 2. [Medline].